What is ANI Pharmaceuticals's price / earnings?

ANI Pharmaceuticals (ANIP) reported price / earnings of 18.7× in Q1 2026.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

ANI Pharmaceuticals ANIP Price / earnings

Price / earnings at other companies

Amneal Pharmaceuticals, Inc.AMRX

32.5×—

ViatrisVTRS

6.5×-6.4×

ALN

Alnylam PharmaceuticalsALNY

87.4×—

Aurinia PharmaceuticalsAUPH

6.6×-21.1×

AmgenAMGN

24.3×-3.9×

OrganonOGN

5.5×+1.8×

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Calculated from ANI Pharmaceuticals’s reported figures.

market cap/net income=18.7×

Based on the most recent quarter.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's price / earnings?: ANI Pharmaceuticals (ANIP) reported price / earnings of 18.7× in Q1 2026.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.